Abstract：
In the current issue of Kidney International, Sinha et al. present data from an open-label, noninferior, randomized controlled trial comparing 12-months of alternate-day prednisolone, given daily during infection, versus levamisole, in children with frequently relapsing or steroid-dependent nephrotic syndrome. This study suggests that both of these strategies are efficacious and safe. Results of this study should redefine the role of levamisole in future guidelines, and a call for global availability of levamisole should be advocated.
摘要：
在本期国际肾脏杂志上，Sinhaetal.从开放标签提供数据，非劣质,比较12个月隔日泼尼松龙的随机对照试验，在感染期间每天给予，与左旋咪唑相比，在经常复发或类固醇依赖性肾病综合征的儿童中。这项研究表明，这两种策略都是有效和安全的。这项研究的结果应该重新定义左旋咪唑在未来指南中的作用，并呼吁在全球范围内使用左旋咪唑。
